Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

62.00 -2.65 (-4.10%)
Streaming Delayed Price Updated: 1:42 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio?
Large-cap stocks surged in the last week. CoreWeave, Super Micro, Coinbase, NRG Energy, Astera Labs, First Solar, Exelixis, Rocket Lab, Hims & Hers, On Holding and Gap were the top performers. 
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month
Hims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month. 
Via Benzinga
HIMS & HERS HEALTH INC (NYSE:HIMS) – A High-Growth Stock Meeting Minervini’s Trend Template
HIMS & HERS HEALTH (NYSE:HIMS) meets Minervini’s Trend Template with strong technicals and explosive earnings growth, making it a high-growth momentum candidate. 
Via Chartmill
Hims & Hers Stock Sparks Retail Trader Frenzy After CEO Announces 'Largest Raise Yet' Of $1B
CEO Andrew Dudum said it was “more than double what we set out for,” thanks to strong investor demand. 
Via Stocktwits
Topics Artificial Intelligence Regulatory Compliance
Exposures Artificial Intelligence Legal Regulatory
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Hims & Hers Stock Soars 29% On Strong Q1 Earnings, Subscriber Growth
Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report released last week. 
Via Benzinga
2 No-Brainer Growth Stocks to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)
Wall Street surges sharply as US-China tariff cuts drive tech stocks higher; pharma sector gains on new Trump drug pricing initiative. 
Via Chartmill
Topics Government World Trade
Exposures Political Tariff
Big News! U.S. and China Trade Deal Shakes Up Markets
Stocks are soaring today on the hope that the trade tensions between the U.S. and China are behind us. 
Via The Motley Fool
Topics World Trade
Exposures Tariff
Unlocking the Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations 
Via Chartmill
Trump's Drug Price Slash Plan Sparks Retail Buzz As Investors Eye Big Pharma Fallout
The proposal, citing a "Most Favored Nation Policy," fueled debate prompted some watchers to question the legality and feasibility of the move, while others speculated on its potential market impact. 
Via Stocktwits
Topics ETFs Government Stocks
Exposures Political US Equities
Retail Bulls Face Off With Record Shorts In Hims & Hers After Q1 Beat
Short interest in Hims & Hers rose to a record high of 37%, continuing a four-week climb, even as the stock surged 42% last week. The company’s quarterly revenue more than doubled, surpassing analyst... 
Via Stocktwits
Topics Earnings
Exposures Financial
The Trade Desk, Walt Disney, And Hims & Hers Health Are Among Top 11 Large-Cap Gainers Last Week (May 5-May 9): Are The Others In Your Portfolio?
Top-performing large-cap stocks last week: TTD, HIMS, PODD, FTAI, ULS, UI, ROK, TOST, DIS, MCHP, and ARMK. Analysts raised price forecasts. 
Via Benzinga
Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Massive Hims & Hers News: $1 Billion on AI and Acquisitions
Hims & Hers is getting $1 billion of rocket fuel. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Hims & Hers Stock Surges On Strong Q1 Results, Falls After Convertible Note Offering
Hims & Hers Health shares have surged 17.4% this week. The company reported strong first-quarter earnings late Monday. 
Via Benzinga
1 Small-Cap Stock to Target This Week and 2 to Keep Off Your Radar
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Stock's 100% Surge Is Squeezing Shorts And It Might Just Be Getting Started
Hedge funds shorting Hims & Hers Health Inc (NYSE:HIMS) may regret it - earnings with a positive surprise could lead to a short squeeze as stock continues to rise, up 96% in past month. 
Via Benzinga
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits
The company makes immunoglobulin products using donated plasma. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial Product Safety
Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible senior notes offering. 
Via Benzinga
Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2
Via Benzinga
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
From Hims & Hers
Via Business Wire
Hims & Hers Has a Superpower in Healthcare
This isn't just any growth stock. 
Via The Motley Fool
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
Via The Motley Fool
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout first-quarter earnings report released late Monday. 
Via Benzinga
Why Novo Nordisk Stock Popped After Earnings
Buying Novo Nordisk stock looks like the cheapest way to invest in GLP-1 drugs. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.